Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.22.62 (
caspase-9
)
7,507
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Both increased cell proliferation and apoptosis play important roles in the malignant growth of glioblastomas. We have demonstrated recently that the differential expression of
protein kinase C
(
PKC
)-eta increases the proliferative capacity of glioblastoma cells in culture; however, specific functions for this novel
PKC
isozyme in the regulation of apoptosis in these tumors has not been defined. In the present study of several glioblastoma cell lines, we investigated the role of
PKC
-eta in preventing UV- and gamma-irradiation-induced apoptosis and in caspase-dependent signaling pathways that mediate cell death. Exposure to UV or gamma irradiation killed 80% to 100% of
PKC
-eta-deficient nonneoplastic human astrocytes and U-1242 MG cells, but had little effect on the
PKC
-eta-expressing U-251 MG and U-373 MG cells.
PKC
-eta appears to mediate resistance to irradiation specifically such that when
PKC
-eta was stably expressed in U-1242 MG cells, more than 80% of these cells developed resistance to irradiation-induced apoptosis. Reducing
PKC
-eta expression by transient and stable expression of antisense
PKC
-eta in wild-type U-251 MG cells results in increased sensitivity to UV irradiation in a fashion similar to U-1242 MG cells and nonneoplastic astrocytes. Irradiation of
PKC
-eta-deficient glioblastoma cells resulted in the activation of
caspase-9
and caspase-3, cleavage of poly (ADP-ribose) polymerase (PARP), and a substantial increase in subdiploid DNA content that did not occur in
PKC
-eta-expressing tumor cells. A specific inhibitor (Ac-DEVD-CHO) of caspase-3 blocked apoptosis in
PKC
-eta-deficient U-1242 MG cells. The data demonstrate that resistance to UV and gamma irradiation in glioblastoma cell lines is modified significantly by
PKC
-eta expression and that
PKC
-eta appears to block the apoptotic cascade at
caspase-9
activation.
...
PMID:Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. 1177 28
Heregulins are a group of growth factors that play diverse and critical roles in the signaling network of the human epidermal growth factor receptor (HER or EGFR) superfamily. Our earlier studies have shown that recombinant heregulinbeta1 (HRG) induces apoptosis in SKBr3 breast cancer cells that overexpress HER2. Here we report molecular mechanisms of HRG-induced apoptosis. HRG treatment of SKBr3 cells for 72 h decreased the level of Bcl-2 protein. HRG treatment led to degradation of poly (ADP-ribose) polymerase (PARP) and activated both
caspase-9
and caspase-7. No significant activation of caspase-3, -6, or -8 was detected. Expression of exogenous caspase-7 by adenovirus-caspase-7 (Ad-casp-7) in SKBr3 cells resulted in apoptosis, which mimicked the effect of HRG treatment. Expression of exogenous caspase-7 had no impact on Bcl-2 expression, but promoted PARP degradation. Two highly selective inhibitors of
protein kinase C
(
PKC
), GF109203X (GF) and Ro318425 (Ro), significantly enhanced HRG-induced apoptosis as determined by flow cytometric analysis and DNA fragmentation assay. Accordingly, the
PKC
inhibitor GF further decreased the level of Bcl-2 protein and further degraded PARP in HRG-treated cells. Assay of
PKC
activity indicated that HRG activated
PKC
in SKBr3 cells, predominantly affecting the
PKCalpha
isoform. To confirm which
PKC
isoform(s) mediated potentiation of HRG-induced apoptosis, the profile of
PKC
isoforms was measured in SKBr3 cells. Five
PKC
isoforms,
PKCalpha
, PKCiota,
PKCzeta
, PKClambda, and
PKCdelta
as well as their receptors (RACK1) were expressed in this cell line. Treatment with
PKC
inhibitors GF and Ro decreased protein levels of both
PKCalpha
and
PKCdelta
at 24 h.
PKCalpha
levels were still depressed at 72 h. GF and Ro had little effect on the expression of other
PKC
isoforms. An inhibitor of classical
PKC
isoforms (Go6976) enhanced HRG-induced apoptosis, whereas the
PKCdelta
selective inhibitor rottlerin did not. As
PKCalpha
was the only classical isoform expressed in SKBr3 cells, the effect of Go6976 on HRG-induced apoptosis largely related to inhibition of
PKCalpha
. Constitutive expression of wild-type
PKCalpha
attenuated the apoptosis produced by HRG and GF. Consequently, HRG-induced apoptosis in SKBr3 cells appeared to involve down-regulation of Bcl-2 protein, activation of
caspase-9
and caspase-7, and degradation of PARP. Inhibition of
PKC
function enhanced HRG-induced apoptosis, leading to synergistic down-regulation of Bcl-2 expression. Impairment of the
PKCalpha
isoform alone was sufficient to potentiate HRG-induced apoptosis.
...
PMID:Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity. 1178 40
In the present study, we characterized oxidative stress-dependent cellular events in dopaminergic cells after exposure to an organic form of manganese compound, methylcyclopentadienyl manganese tricarbonyl (MMT). In pheochromocytoma cells, MMT exposure resulted in rapid increase in generation of reactive oxygen species (ROS) within 5--15 min, followed by release of mitochondrial cytochrome C into cytoplasm and subsequent activation of cysteine proteases,
caspase-9
(twofold to threefold) and caspase-3 (15- to 25-fold), but not caspase-8, in a time- and dose-dependent manner. Interestingly, we also found that MMT exposure induces a time- and dose-dependent proteolytic cleavage of native protein kinase Cdelta (
PKCdelta
, 72-74 kDa) to yield 41 kDa catalytically active and 38 kDa regulatory fragments. Pretreatment with caspase inhibitors (Z-DEVD-FMK or Z-VAD-FMK) blocked MMT-induced proteolytic cleavage of
PKCdelta
, indicating that cleavage is mediated by caspase-3. Furthermore, inhibition of
PKCdelta
activity with a specific inhibitor, rottlerin, significantly inhibited caspase-3 activation in a dose-dependent manner along with a reduction in
PKCdelta
cleavage products, indicating a possible positive feedback activation of caspase-3 activity by
PKCdelta
. The presence of such a positive feedback loop was also confirmed by delivering the catalytically active
PKCdelta
fragment. Attenuation of ROS generation, caspase-3 activation, and
PKCdelta
activity before MMT treatment almost completely suppressed DNA fragmentation. Additionally, overexpression of catalytically inactive
PKCdelta
(K376R) (dominant-negative mutant) prevented MMT-induced apoptosis in immortalized mesencephalic dopaminergic cells. For the first time, these data demonstrate that caspase-3-dependent proteolytic activation of
PKCdelta
plays a key role in oxidative stress-mediated apoptosis in dopaminergic cells after exposure to an environmental neurotoxic agent.
...
PMID:Caspase-3-dependent proteolytic cleavage of protein kinase Cdelta is essential for oxidative stress-mediated dopaminergic cell death after exposure to methylcyclopentadienyl manganese tricarbonyl. 1188 May 3
We studied the role of
protein kinase C
isoform
PKCdelta
in ceramide (Cer) formation, as well as in the mitochondrial apoptosis pathway induced by anticancer drugs in prostate cancer (PC) cells. Etoposide and paclitaxel induced Cer formation and apoptosis in
PKCdelta
-positive LNCaP and DU145 cells but not in
PKCdelta
-negative LN-TPA or PC-3 cells. In contrast, these drugs induced mitotic cell cycle arrest in all PC cell lines. Treatment with Rottlerin, a specific
PKCdelta
inhibitor, significantly inhibited drug-induced Cer formation and apoptosis in LNCaP cells, as did overexpression of dominant negative-type
PKCdelta
. Overexpression of wild-type
PKCdelta
had an opposite effect in PC-3 cells. Notably, etoposide induced biphasic Cer formation in LNCaP cells. The early and transient Cer increase resulted from de novo Cer synthesis, while the late and sustained Cer accumulation was derived from sphingomyelin hydrolysis by neutral sphingomyelinase (nSMase). Cer, in turn, induced mitochondrial translocation of
PKCdelta
and stimulated the activity of this kinase, promoting cytochrome c release and
caspase-9
activation. Furthermore, the specific
caspase-9
inhibitor LEHD-fmk significantly inhibited etoposide-induced nSMase activation, Cer accumulation, and
PKCdelta
mitochondrial translocation. These results indicate that
PKCdelta
plays a crucial role in activating anticancer drug-induced apoptosis signaling by amplifying the Cer-mediated mitochondrial amplification loop.
...
PMID:Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. 1190 Nov 79
We studied the role of the mitogen-activated protein kinase (MAPK) pathway in the regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in breast tumor MCF-7 cells. We found that addition of a
protein kinase C
(
PKC
) activator to MCF-7 cultures prevented TRAIL-induced apoptosis, by inhibiting a step downstream of both caspase-8 activation and BID cleavage. TRAIL-induced translocation of Bax from cytosol to mitochondria, release of cytochrome c from mitochondria and activation of
caspase-9
were all inhibited by
PKC
activation.
PKC
-mediated prevention of mitochondrial apoptotic events and apoptosis was found to be dependent on the MAPK pathway. Since TRAIL is a ligand of potential use in antineoplastic clinical trials, our findings may provide relevant information in cancer therapy.
...
PMID:Stimulation of the mitogen-activated protein kinase pathway antagonizes TRAIL-induced apoptosis downstream of BID cleavage in human breast cancer MCF-7 cells. 1208 20
The serine/threonine protein kinase C (
PKC
) has been implicated in the regulation of drug resistance and cell survival in many types of cancer cells. However, the one or more precise mechanisms remain elusive. In this study, we have identified and determined the mechanism by which
PKC
-epsilon, a novel
PKC
isoform, modulates drug resistance in lung cancer cells. Western blot analysis demonstrates that expression of
PKC
-epsilon, but not other
PKC
isoforms, is associated with the chemo-resistant phenotype of non-small cell lung cancer (NSCLC) cell lines. Northern blotting and nuclear run-on transcription analysis further reveals that the failure of expression of
PKC
-epsilon in the chemo-sensitive phenotype of small cell lung cancer (SCLC) cells results from transcriptional inactivation of the gene. Importantly, forced expression of
PKC
-epsilon in NCI-H82 human SCLC cells confers a significant resistance to the chemotherapeutic drugs, etoposide and doxorubicin. Resistance is characterized by a significant reduction in apoptosis in
PKC
-epsilon-expressing cells. Treatment of NCI-H82 cells with etoposide induces a series of time-dependent events, including the release of cytochrome c from the mitochondria to the cytosol, activation of
caspase-9
and caspase-3, and cleavage of poly(ADP-ribose) polymerase (PARP). All of these events are blocked by
PKC
-epsilon expression. Furthermore, caspase-specific inhibitors, z-VAD-fmk and z-DEVD-fmk, significantly attenuate the accumulation of sub-G(1) population and block the PARP cleavage in response to etoposide. These results suggest that
PKC
-epsilon prevents cells from undergoing apoptosis through inhibition of the mitochondrial-dependent caspase activation, thereby leading to cell survival. Finally, down-regulation of
PKC
-epsilon expression by the antisense cDNA in NSCLC cells results in increased sensitivity to etoposide. Taken together, our findings suggest an important role for
PKC
-epsilon in regulating survival of lung cancer cells.
...
PMID:Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. 1212 73
The
protein kinase C
(
PKC
) signal transduction pathway negatively regulates receptor-initiated cell death. In HeLa cells, tumor necrosis factor-alpha (TNF)-mediated cell death involved mitochondria and was blocked by the overexpression of Bcl-2. The
PKC
-specific inhibitor bisindolylmaleimide and the
PKCdelta
inhibitor rottlerin enhanced TNF-induced cell death. We have investigated if potentiation of TNF-induced cell death by rottlerin involved amplification of the mitochondrial pathway. TNF induced cleavage of the proapoptotic protein Bid and release of mitochondrial cytochrome c. Rottlerin enhanced activation of caspase-8 and cleavage of Bid. It also enhanced activation of
caspase-9
but it did not increase cytochrome c in the cytosol. It, however, increased release of mitochondrial apoptosis-inducing factor (AIF) to the cytosol. Overexpression of Bcl-2 prevented release of both cytochrome c and AIF to the cytosol. Prolonged exposure (> or =6 h) of HeLa cells to rottlerin and TNF decreased the level of cytochrome c but not of AIF in the cytosol. These results suggest that rottlerin activates a cytochrome-c-independent cell death pathway to potentiate cell death by TNF.
...
PMID:Potentiation of tumor necrosis factor-alpha-induced cell death by rottlerin through a cytochrome-C-independent pathway. 1216 76
The pathway of cell death depends on the apoptotic stimuli as well as on the cell type. In the present study, we have compared how extrinsic and intrinsic cell death pathways are regulated by the
protein kinase C
(
PKC
) signal transduction pathway in the same cell type. PDBu, an activator of
PKC
, potentiated cell death mediated by the DNA damaging agent cisplatin but it blocked tumor necrosis factor-alpha (TNF)-induced cell death in HeLa cells. Conversely, rottlerin, an inhibitor of
PKCdelta
, decreased sensitivity of HeLa cells to cisplatin but it potentiated TNF-induced cell death. Although both TNF and cisplatin caused activation of caspases,
PKC
modulators had opposing effects on caspase activation. Rottlerin inhibited mitochondrial or intrinsic cell death pathway by inhibiting cisplatin-induced processing of apical
caspase-9
and its downstream caspases. In contrast, it potentiated receptor-initiated or extrinsic cell death pathway by enhancing activation of caspase-2 and/or caspase-8. These results suggest that
PKC
acts at distinct steps to regulate receptor-mediated and DNA damage-induced apoptosis.
...
PMID:Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C. 1237 88
In various mammalian cells, two group IIb metals, cadmium and zinc, induce several morphological and biochemical effects that are salient features of programmed cell death. In C6 rat glioma cells, cadmium caused externalization of phosphatidylserine, breakdown of the mitochondrial membrane potential, activation of
caspase-9
, internucleosomal DNA fragmentation, chromatin condensation, and nuclear fragmentation. In NIH3T3 murine fibroblasts, cadmium-induced apoptosis was inhibited by overexpression of the antiapoptotic protein Bcl-2. Cadmium-induced DNA fragmentation in C6 cells was independent of inhibition of protein kinase A (PKA),
protein kinase C
(
PKC
), mitogen-activated protein kinase (MAPK), phosphatidylinositol-3-kinase, Ca-calmodulin-dependent protein kinase, and protein kinase G. Zinc at moderate concentrations (10-50 microM) protected against programmed cell death induced by cadmium, whereas deprivation of zinc by the membrane-permeable chelator N,N,N',N-terakis-(2-pyridylmethyl)ethylenediamine (TPEN) caused cell death with features characteristic of apoptosis. On the other hand, at elevated extracellular levels (150-200 microM), zinc alone caused programmed cell death in C6 cells. Zinc-induced apoptosis was independent of inhibition of PKA,
PKC
, guanylate cyclase and MAPK, but it was suppressed in the presence of 100 microM lanthanum chloride.
...
PMID:Induction of apoptosis in mammalian cells by cadmium and zinc. 1242 48
Alveolar epithelial and mesothelial cells undergo apoptosis in response to asbestos, a phenomenon that may be important in injury and/or initiation of compensatory proliferation. Here, we report a functional role of protein kinase (
PKC
)delta in apoptosis by crocidolite asbestos. We first show that asbestos increases the kinase activity of
PKC
delta in alveolar type II epithelial cells (C10 line) and causes its translocation to mitochondria, events associated with
caspase-9
cleavage and apoptosis as detected by the Apostain technique. Pretreatment of C10 cells with rottlerin (Rot), a
PKC
delta-selective inhibitor, before addition of asbestos prevented cleavage of
caspase-9
and blocked the appearance of apoptotic cells. Asbestos-induced apoptosis also was inhibited in cells stably expressing a dominant-negative kinase-deficient mutant of
PKC
delta (dnPKC delta), but not dnPKC alpha. Activities of
PKC
alpha and PKC zeta increased after exposure to asbestos, but neither isoform migrated to mitochondria. A general inhibitor of PKCs, bisindolylmaleimide I, had no effect on asbestos-induced apoptosis. Hydrogen peroxide (H2O2) induced activation of PKCs delta, alpha, zeta, and theta, translocation of
PKC
delta to mitochondria, and
caspase-9
cleavage. However, H2O2-induced apoptosis was not inhibited by cell lines stably expressing either dnPKC delta or dnPKC alpha, suggesting that activation of
PKC
delta has a distinct role in the development of asbestos-induced apoptosis.
...
PMID:Asbestos-induced apoptosis is protein kinase C delta-dependent. 1262 42
<< Previous
1
2
3
4
5
6
7
8
Next >>